REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPH and the CUSIP is 76152G100. A total of 32 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q3 2023. The put-call ratio across all filers is 1.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,283,176 | -16.1% | 877,700 | +0.7% | 0.00% | -100.0% |
| Q2 2023 | $5,105,818 | +342.6% | 871,300 | +216.5% | 0.00% | – |
| Q1 2023 | $1,153,541 | -17.0% | 275,308 | -15.8% | 0.00% | – |
| Q4 2022 | $1,389,028 | +137.8% | 326,830 | -11.1% | 0.00% | – |
| Q3 2022 | $584,000 | +114.7% | 367,518 | +48.4% | 0.00% | – |
| Q2 2022 | $272,000 | +38.1% | 247,600 | +209.1% | 0.00% | – |
| Q1 2022 | $197,000 | +23.1% | 80,103 | +41.2% | 0.00% | – |
| Q4 2021 | $160,000 | +48.1% | 56,746 | +113.1% | 0.00% | – |
| Q3 2021 | $108,000 | – | 26,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 564,000 | $2,752,320 | 0.84% |
| EMC Capital Management | 123,915 | $613 | 0.45% |
| Ikarian Capital, LLC | 5,095 | $2,486,360 | 0.30% |
| SABBY MANAGEMENT, LLC | 44,593 | $217,614 | 0.16% |
| ARMISTICE CAPITAL, LLC | 600,000 | $2,928,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 70,181 | $342 | 0.03% |
| Caption Management, LLC | 275,200 | $1,342,976 | 0.02% |
| Caption Management, LLC | 216,600 | $1,057,008 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 109,700 | $535,336 | 0.01% |
| J. Goldman & Co LP | 75,000 | $366,000 | 0.01% |